Commercialization of biopolymers

A large variety of biopolymers, such as polysaccharides, polyesters, and polyamides, are naturally synthesized by microorganisms. These biopolymers range from viscous solutions to plastics and their physical properties which are dependent on the composition and molecular weight of the polymer. Genetic engineering of microorganisms has provided an enormous potential for the biotechnological production of biopolymers with desired properties suitable for medical application such as tissue engineering, material science, drug delivery and bioplastics. There are several benefits in commercializing biopolymers mostly for sustainable development, renewability and eco-friendly aspects. Bioplastics can be manufactured mainly with three different methods, one is modifying naturally occurring polymers such as starch, cellulose. Second, is by polymerizing bio-based monomers that are produced by fermentation and the last one, as mentioned earlier, by genetically modified microbes and plants. There are several technologies and processes designed for biopolymer production that include extrusion, film blowing, thermoforming, fermentation, injection moulding, etc.

  • Processing technologies
  • Raw materials resource base
  • Transition to bio based products
  • Potential benefits of biopolymer industries
  • Products of biopolymers

Related Conference of Commercialization of biopolymers

September 22-23, 2025

29th Materials Science and Nano Tech Expo

Amsterdam, Netherlands
October 28-29, 2025

3rd World Summit on Emerging Materials and Nanotechnology

Vancouver, Canada
October 28-29, 2025

9th International Conference on Smart Materials

Vancouver, Canada
August 25-26, 2026

19th Annual Conference on Stem Cell and Biomaterials

Amsterdam, Netherlands

Commercialization of biopolymers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in